Today: May 23, 2024
January 12, 2024
1 min read

Accelerating Insight to Therapeutics: Introducing Arena BioWorks’ Biomedical Breakthroughs

TLDR: Arena BioWorks has launched as a biomedical research institute that will create for-profit biotech companies to develop lifesaving therapeutics. The company, which is supported by co-founders Harvard University scientist Stuart Schreiber, former Bain Capital Co-Chair Steve Paglicua and Tom Cahill of venture capital firm Newpath Partners, will use private funding to quickly translate insights into discovery. Use of drug discovery platforms will also be supported through preclinical studies and beyond.

Previous Story

Now is the Perfect Time for Corporate Venture Capital, Norton Rose

Next Story

D-Orbit Hits the Jackpot with €100m in Series C Funding

Latest from Blog

Majority secures $20M investment boost

Article Summary TLDR: Key Points: Majority, a Miami-based provider of mobile banking and international services for migrants, raised $20M in funding. The funding round included a mix of equity and debt financing
Go toTop